Earlier this month, the FDA removed Lilly’s meds from its shortage list, putting an end to a 22-month supply squeeze. While undoubtedly a win for Lilly, the move drew the ire of compounding ...
weight-loss drug Wegovy is no longer considered to be in short supply in the U.S. Certain doses of the drug, along with its sibling drug Ozempic, have been on the FDA’s drug shortage list for ...
The national office vacancy rate is set to rise to around 20% by the end of this year, according to commercial real estate firm CBRE. At the same time, the US faces a housing supply problem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback